ComparecontextflowvsQure.ai

What is contextflow?

contextflow develops AI-based chest CT software for radiology, with products that support the detection, quantification, and assessment of lung abnormalities within existing imaging workflows. Its core product, ADVANCE Chest CT, provides computer-aided detection and analysis for suspected lung cancer, interstitial lung disease (ILD), and COPD, while additional products extend the suite to malignancy assessment and incidental pulmonary embolism.

1. ADVANCE Chest CT: the software detects and quantifies pulmonary nodules, tracks changes in nodules over time, analyzes lung tissue, and evaluates multiple chest CT imaging patterns. It also provides reference cases and differential-diagnosis information to support radiologists during interpretation.
2. PACS-integrated workflow: contextflow is designed to surface findings inside the radiologist’s native viewer. Depending on the integration, detected nodules, quantitative measurements, secondary captures, and structured-reporting data can be made available without requiring a separate diagnostic workspace.
3. Broader chest CT suite: contextflow’s current portfolio includes RevealAI-Lung for lung-nodule malignancy scoring and CINA-iPE for incidental pulmonary embolism, alongside ADVANCE Chest CT. Buyers should therefore distinguish between capabilities native to ADVANCE and those delivered through separate products in the wider solution suite.
4. Clinical and regulatory fit: ADVANCE Chest CT is presented as a CE-marked medical device under the European MDR and is intended to support, rather than replace, radiologist interpretation. Healthcare organizations should assess intended use, regional regulatory status, PACS compatibility, local validation, and governance before deployment.

contextflow is most relevant to radiology departments and imaging organizations that need structured chest CT analysis for lung cancer, ILD, COPD, and related thoracic findings while keeping results integrated with existing reporting workflows. In June 2026, 4DMedical announced a binding agreement to acquire contextflow, positioning its structural chest imaging tools within a broader respiratory imaging portfolio.

Qure.ai is a radiology AI platform for hospitals and global health programs, supporting chest X-ray, CT, and stroke imaging workflows across international markets.

1. Clinical role: It flags findings for triage and prioritization rather than autonomous interpretation, so radiologists remain responsible for reviewing every study.
2. Workflow fit: The platform focuses on radiology-specific deployment, including PACS and worklist integration, with particular depth across chest and stroke imaging.
3. Evaluation priorities: Buyers should verify clearance and validation by clinical indication, local reimbursement conditions, and impact metrics for each reading workflow.
4. Commercial model: Pricing is sales-led and scoped per buyer rather than posted publicly, making implementation planning and support requirements important before adoption.

Its suitability depends on approved use, workflow integration, market-specific requirements, and consistent clinical oversight.